Abstract
Chemoradiotherapy is an important treatment paradigm in oncology and is part of the curative treatment for many solid cancers, such as lung, pancreatic and cervical cancers. One of the main goals in oncology research is to develop approaches that can improve the efficacy of chemoradiotherapy while minimizing treatment toxicity. A new and exciting approach is to incorporate advances in nanomedicine into chemoradiotherapy. Nanoparticles possess unique properties, such as preferential accumulation in tumors and minimal uptake in normal tissues, that make them ideally suited for delivering chemotherapy in chemoradiotherapy. In this review, we plan to discuss the rationale and evidence for applying nanomedicine to chemoradiotherapy.
Keywords: Nanoparticle radiosensitization, chemoradiation nanoparticles, nanomedicine, chemoradiation, nanoparticle radiotherapy, nanoparticle radiosensitizer, nanoparticle chemoradiotherapy, translational nanomedicine, tumors, toxicity
Current Pharmaceutical Design
Title:Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine
Volume: 18 Issue: 19
Author(s): Michael Edward Werner, Michael Bonner Foote and Andrew Zhuang Wang
Affiliation:
Keywords: Nanoparticle radiosensitization, chemoradiation nanoparticles, nanomedicine, chemoradiation, nanoparticle radiotherapy, nanoparticle radiosensitizer, nanoparticle chemoradiotherapy, translational nanomedicine, tumors, toxicity
Abstract: Chemoradiotherapy is an important treatment paradigm in oncology and is part of the curative treatment for many solid cancers, such as lung, pancreatic and cervical cancers. One of the main goals in oncology research is to develop approaches that can improve the efficacy of chemoradiotherapy while minimizing treatment toxicity. A new and exciting approach is to incorporate advances in nanomedicine into chemoradiotherapy. Nanoparticles possess unique properties, such as preferential accumulation in tumors and minimal uptake in normal tissues, that make them ideally suited for delivering chemotherapy in chemoradiotherapy. In this review, we plan to discuss the rationale and evidence for applying nanomedicine to chemoradiotherapy.
Export Options
About this article
Cite this article as:
Edward Werner Michael, Bonner Foote Michael and Zhuang Wang Andrew, Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine, Current Pharmaceutical Design 2012; 18 (19) . https://dx.doi.org/10.2174/138161212800626229
DOI https://dx.doi.org/10.2174/138161212800626229 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanomedicine for Cancer Therapy Using Autophagy: An Overview
Current Topics in Medicinal Chemistry Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy Design of Combretastatin A-4 Analogs as Tubulin Targeted Vascular Disrupting Agent with Special Emphasis on Their Cis-Restricted Isomers
Current Pharmaceutical Design Receptor Binding Inhibitor Suppresses Carcinogenesis of Cervical Cancer by Depressing Levels of FSHR and ERβ in Mice
Anti-Cancer Agents in Medicinal Chemistry Trypsin-Chymotrypsin Inhibitors from Vigna mungo Seeds
Protein & Peptide Letters Emerging Technologies for Fertility Preservation in Female Patients
Current Women`s Health Reviews Inorganic Nanomedicines and their Labeling for Biological Imaging
Current Topics in Medicinal Chemistry Targeting Protein Degradation in the Nervous System
Current Medicinal Chemistry - Central Nervous System Agents p53: Fighting Cancer
Current Cancer Drug Targets Diverse Roles of GADD45α in Stress Signaling
Current Protein & Peptide Science Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Increased Neuronal Injury in Clock Gene Per-1 Deficient-Mice after Cerebral Ischemia
Current Neurovascular Research Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Hypoxia-Inducible Factor 1 in Tumor Radioresistance
Current Signal Transduction Therapy Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems
Current Drug Targets Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy – Part-3
Current Topics in Medicinal Chemistry A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines
Current Medicinal Chemistry Anti-Cancer Targeting Telomerase Inhibitors: β-Rubromycin and Oleic Acid
Mini-Reviews in Medicinal Chemistry Plasma-Free Amino Acid Profiling of Nasal Polyposis Patients
Combinatorial Chemistry & High Throughput Screening Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
Medicinal Chemistry